AKEBIA THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $131.00K, a 67.95% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $151.00K, a 81.93% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $78.00K, a 11.43% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $83.00K, a 66.00% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $230.00K, a 50.33% increase from fiscal 2024.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $153.00K, a 80.00% increase from fiscal 2023.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $85.00K, a 79.27% decline from fiscal 2022.
- AKEBIA THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $410.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $131.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $230.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $151.00K 10-Q · filed 2025-11-10 | |
| 2025-03-31 | $78.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $153.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $83.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $70.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $85.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $50.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $34.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $410.00K 10-K · filed 2024-03-14 | |
| 2018-12-31 | $482.00K 10-K · filed 2019-03-26 | |
| 2017-12-31 | $353.00K 10-K · filed 2019-03-26 | |
| 2016-12-31 | $105.00K 10-K · filed 2019-03-26 | |
| 2015-12-31 | $220.00K 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |